#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebellar ataxia Renal cell carcinoma Cutaneous T-cell lymphoma stage II Neutropenia Necrotising enterocolitis neonatal Brain stem glioma Renal cancer metastatic Hereditary haemorrhagic telangiectasia Solitary fibrous tumour Breast cancer metastatic Peritoneal neoplasm Neoplasm Pancreatic neuroendocrine tumour Cystic fibrosis gastrointestinal disease Orthostatic hypotension More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy – Trials in Disease Mast cell activation syndrome – Treatment Marfan’s syndrome – Life with Disease Prolymphocytic leukaemia – Trials in Disease Glycogen storage disease type I – Life with Disease Malignant fibrous histiocytoma – Life with Disease X-linked lymphoproliferative syndrome – Treatment Bronchiolitis obliterans syndrome – Life with Disease Bronchiolitis obliterans syndrome – Diagnostics Sjogren’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SAROGLITAZAR HEMIMAGNESIUM IHMA-2121908-1 LINAPRAZAN GLURATE Etrasimod Arginine TUVATEXIB Rasburicase Tislelizumab Enasidenib Mesilate Neob Nusinersen Luspatercept Natalizumab Fluorodopa (18F) Rimegepant Sumatriptan Succinate Danicopan Rosuvastatin Zinc CICLOPIROX Vusolimogene Oderparepvec Erythromycin More therapies…

    Learn about Your Condition

    Mumps Psoriasis Eye inflammation Lymphocyte adoptive therapy Developmental hip dysplasia Mucosal inflammation Large cell lung cancer stage 0 Uterine cancer Malignant oligodendroglioma Myotonic dystrophy CDKL5 deficiency disorder Infertility Rectal cancer Organ donor Pancreatic fistula More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Peritoneal mesothelioma malignant

  • Study on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
    • Nivolumab
    The Netherlands

  • Study of Tremelimumab for Patients with Unresectable Malignant Mesothelioma

    Recruiting

    2 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Tremelimumab
    Italy

  • Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic thyroid cancer
    • Thymic carcinoma
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Fluorouracil
    France

  • Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Talazoparib
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!